Where does Juvena Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Juvena Therapeutics's 2 recorded funding rounds.

Premier Alternatives

Juvena Therapeutics

Redwood City, CA · Founded 2017 · Privately Held (backing)

Developer of a biopharmaceutical drug discovery platform intended to discover novel protein-based therapeutics. Juvena Therapeutics is based in Redwood City, CA and was founded in 2017. Its last reported valuation was $100 million in Nov 2022. It has raised $132 million across 2 recorded rounds; the latest was a $30.5 million early-stage round in Jun 2025.

Last reported valuation

$100.0M

Oct 2026

Priced at

—

Total raised

$132.2M

Last round

Early Stage VC

Jun 2025

Cap table — not yet on record

Juvena Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Juvena Therapeutics with a free account

·The complete investor list: 34 names
·Watch Juvena Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Juvena Therapeutics

Where does Juvena Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Juvena Therapeutics's 2 recorded funding rounds.